- Home
- STGW vs ORGO Comparison
STGW vs ORGO Comparison
Compare STGW & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STGW
- ORGO
- Stock Information
- Founded
- STGW 1980
- ORGO 1985
- Country
- STGW United States
- ORGO United States
- Employees
- STGW N/A
- ORGO N/A
- Industry
- STGW
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- STGW
- ORGO Health Care
- Exchange
- STGW Nasdaq
- ORGO Nasdaq
- Market Cap
- STGW 683.2M
- ORGO 665.8M
- IPO Year
- STGW N/A
- ORGO N/A
- Fundamental
- Price
- STGW $5.43
- ORGO $4.22
- Analyst Decision
- STGW Strong Buy
- ORGO Buy
- Analyst Count
- STGW 6
- ORGO 2
- Target Price
- STGW $9.08
- ORGO $5.50
- AVG Volume (30 Days)
- STGW 761.4K
- ORGO 1.4M
- Earning Date
- STGW 05-08-2025
- ORGO 05-08-2025
- Dividend Yield
- STGW N/A
- ORGO N/A
- EPS Growth
- STGW 1724.82
- ORGO N/A
- EPS
- STGW 0.02
- ORGO N/A
- Revenue
- STGW $2,841,216,000.00
- ORGO $482,043,000.00
- Revenue This Year
- STGW $4.00
- ORGO $3.31
- Revenue Next Year
- STGW $9.58
- ORGO $12.50
- P/E Ratio
- STGW $271.50
- ORGO N/A
- Revenue Growth
- STGW 12.43
- ORGO 11.29
- 52 Week Low
- STGW $4.75
- ORGO $2.17
- 52 Week High
- STGW $8.18
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- STGW 44.51
- ORGO 47.71
- Support Level
- STGW $5.18
- ORGO $3.57
- Resistance Level
- STGW $5.51
- ORGO $4.38
- Average True Range (ATR)
- STGW 0.33
- ORGO 0.34
- MACD
- STGW 0.00
- ORGO -0.00
- Stochastic Oscillator
- STGW 49.28
- ORGO 75.27
About STGW Stagwell Inc.
Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; and Communications Network. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.